[Effect of adjuvant immunotherapy with Nocardia rubra cell-wall skeleton in lung cancer]. 1983

K Yasumoto, and Y Ichinose, and H Yaita, and K Tanaka, and N Hara, and M Ohta, and N Hirota, and K Nomoto, and K Inokuchi, and Y Yamamura

A randomized clinical trial of intrapleural Nocardia rubra cell-wall skeleton (N-CWS) followed by intradermal N-CWS was performed against lung cancer patients from November, 1977 to June 1981. Totally, 190 patients were entered into this trial. The N-CWS treatment was effective in terms of prolongation of remission duration against not only operable but also inoperable patients. However, significant improvement of survival rate was observed only in operable patients, especially curative+relatively curative resection-group (p less than 0.05). The mode of recurrence was classified as local recurrence and distant metastasis in the curative+relatively curative resection-group. The rates of distant metastasis were 34.1 and 17.6%, respectively, in the control and the N-CWS groups. The rate of local recurrence was 13.6% in the control group, however, no local recurrence was observed in the C-NWS group. These results indicate the clinical effectiveness of the N-CWS treatment especially in curatively resectable lung cancer. No serious side effect was experienced during this trial.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009615 Nocardia A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for humans and animals. Micropolyspora
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Yasumoto, and Y Ichinose, and H Yaita, and K Tanaka, and N Hara, and M Ohta, and N Hirota, and K Nomoto, and K Inokuchi, and Y Yamamura
February 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
K Yasumoto, and Y Ichinose, and H Yaita, and K Tanaka, and N Hara, and M Ohta, and N Hirota, and K Nomoto, and K Inokuchi, and Y Yamamura
November 1983, Cancer research,
K Yasumoto, and Y Ichinose, and H Yaita, and K Tanaka, and N Hara, and M Ohta, and N Hirota, and K Nomoto, and K Inokuchi, and Y Yamamura
January 1985, Nihon Kyobu Shikkan Gakkai zasshi,
K Yasumoto, and Y Ichinose, and H Yaita, and K Tanaka, and N Hara, and M Ohta, and N Hirota, and K Nomoto, and K Inokuchi, and Y Yamamura
January 1992, Cancer immunology, immunotherapy : CII,
K Yasumoto, and Y Ichinose, and H Yaita, and K Tanaka, and N Hara, and M Ohta, and N Hirota, and K Nomoto, and K Inokuchi, and Y Yamamura
January 1984, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
K Yasumoto, and Y Ichinose, and H Yaita, and K Tanaka, and N Hara, and M Ohta, and N Hirota, and K Nomoto, and K Inokuchi, and Y Yamamura
February 1979, Gan,
K Yasumoto, and Y Ichinose, and H Yaita, and K Tanaka, and N Hara, and M Ohta, and N Hirota, and K Nomoto, and K Inokuchi, and Y Yamamura
January 2022, Pathology oncology research : POR,
K Yasumoto, and Y Ichinose, and H Yaita, and K Tanaka, and N Hara, and M Ohta, and N Hirota, and K Nomoto, and K Inokuchi, and Y Yamamura
April 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
K Yasumoto, and Y Ichinose, and H Yaita, and K Tanaka, and N Hara, and M Ohta, and N Hirota, and K Nomoto, and K Inokuchi, and Y Yamamura
February 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
K Yasumoto, and Y Ichinose, and H Yaita, and K Tanaka, and N Hara, and M Ohta, and N Hirota, and K Nomoto, and K Inokuchi, and Y Yamamura
January 1981, Cancer treatment reports,
Copied contents to your clipboard!